Skip to Main Content

Monthly Archives: January 2021

01.19.21

Most U.S. Health Plans Must Now Cover the Full Cost of PrEP, But More Than the Medication Is Needed for HIV Prevention

By O’Neill Institute

This expert column was written by Landon Myers and Sean Bland. Pre-exposure prophylaxis, or PrEP, is a medication that people at risk for HIV take to prevent HIV acquisition. When taken as prescribed, it is highly effective for preventing HIV acquisition. Despite its efficacy, PrEP uptake has been relatively low in the United States, in […]

Tags:
Thematic Areas: Infectious Diseases

01.14.21

India Must Have Vaccine Transparency for the World’s Largest Immunization Program to Succeed

By O’Neill Institute

This expert column was written by Kashish Aneja.  On January 16, India is set to launch the world’s largest national immunization programme with two of its ‘made in India’ vaccines. India sits at the center of the COVID-19 response, not just because it has the second-highest number of global cases, or only due to its […]

Tags:

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.